The SLC16A3 gene gives cells instructions for a transporter that moves lactate, a byproduct of energy use, out of the cell and helps keep acid levels balanced. If it does not work properly, some cells may struggle to clear lactate and maintain normal energy handling. This gene plays an important role in tissues that burn fuel quickly, including working muscles. In medicine, it is most often discussed in cancer research because many tumors rely on this transport system to keep growing.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes give the directions for producing proteins, the parts of cells that do much of the work. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
SLC16A3Gene function
What if the gene works
The SLC16A3 gene helps cells move lactate, a waste product of sugar use, across the cell membrane. This supports energy production and helps control acid levels, especially in active tissues such as muscle.
Risk
What if the gene does not work
Milder to more severe variants in the SLC16A3 gene can reduce how well cells move lactate (a byproduct of making energy) and hydrogen ions across the cell membrane. This can upset cellular acid balance and energy handling.
Treatment
What does that mean for your treatment
No treatment or management approach is currently established specifically for pathogenic variants in the SLC16A3 gene. The SLC16A3 gene is being studied in cancer as a biomarker and possible drug target, especially in tumors that rely heavily on lactate transport.
Gene function
What if the gene works
When cells are burning sugar fast, they need a way to move lactate out and keep their internal balance steady. The SLC16A3 gene provides instructions for a transport protein that helps with this everyday task. Understanding the SLC16A3 gene’s function helps explain how active cells keep energy production moving.
Its protein moves lactate out of the cell when sugar is being used for quick energy. This helps active cells avoid a buildup of lactate inside.
SLC16A3 carries lactate together with a hydrogen ion, a tiny charged particle linked to acidity. This helps cells keep their pH, the level of acidity or alkalinity, in a workable range.
By clearing lactate, this transporter helps cells keep making energy from sugar during short bursts of high demand. This is especially useful in tissues that rely on fast, flexible fuel use.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the SLC16A3 gene can alter the shape or stability of its transport protein, so less of it reaches the cell surface or it moves lactate less effectively. To understand how variants influence the SLC16A3 gene's function, it helps to know that some variants cause a partial drop in activity, while more severe variants can greatly disrupt protein folding or membrane transport. These differences can change how strongly cells handle acid balance and energy byproducts.
How variants are linked to conditions
The SLC16A3 gene does not yet have a broadly confirmed link to a specific inherited health condition, though research on how SLC16A3 variants are linked to conditions is still developing. Anyone with a confirmed change in the SLC16A3 gene should rely on guidance from their doctor or genetic counselor for interpretation.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal feature of human biology. Most do not directly affect health and instead reflect natural differences among people. In many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences play a role. In some situations, though, one well-studied variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC16A3 gene itself. Anyone with concerns about personal or family risk can talk with a doctor or genetic counselor.
Inheritance of SLC16A3 variants
There is not yet a broadly confirmed Mendelian pattern for how SLC16A3 gene variants are inherited in relation to a specific human condition, so the answer to how SLC16A3 gene variants are inherited remains limited to general genetics. The SLC16A3 gene is located on chromosome 17, which is an autosome. That means each person inherits one copy of the SLC16A3 gene from their mother and one copy from their father. As research develops, a clearer condition-specific inheritance pattern may be defined.
What does my SLC16A3 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific well-established genetic condition for the SLC16A3 gene, though this can change as research develops. If you have a specific SLC16A3 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can help put that result in the right family context.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SLC16A3 gene, SLC16A3 genetic testing uses a blood sample, saliva, or cheek swab to read the gene’s DNA sequence and look for variants. Results may identify a specific variant, show no relevant variant, or find a change whose health meaning is still unclear.
When should I consider getting a genetic test?
There is not yet a broadly established, SLC16A3-specific reason for genetic testing in routine care. Decisions about testing are usually based on your personal health history, family history, and the advice of a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, yet how much it explains varies with the condition and the kind of variant present. Over time, the way the body functions is also shaped by factors like lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context instead of certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. These differences are common and can influence both how well a medicine helps and how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape the way people respond to medications. It studies patterns between genes and drugs to help explain why the same treatment may work differently in different people. For many medicines, genes can affect how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC16A3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. Questions about side effects, treatment changes, or concerns about how well a medicine is working are best discussed with your doctor. SLC16A3 is being studied mostly in cancer research for how tumors use energy, not as a routine guide for medication response.
History
SLC16A3 entered the genetics literature in the late 1990s, when researchers were mapping a family of related transport genes in human tissues. Initially understood only through visible traits, later recognized as tied to a specific gene, this line of work helped separate SLC16A3 from closely related family members. Building on this early work, scientists linked SLC16A3 to the growing field of tumor metabolism, especially as interest rose in how cancer cells handle lactate. In the 2000s and 2010s, studies in breast cancer and other solid tumors brought the gene more attention as a possible marker of aggressive disease. Today, SLC16A3 is best known in research history for helping shape modern thinking about cancer metabolism.